Emerging issues for our nation's health: The intersection of marijuana use and cardiometabolic disease risk

Journal of Addictive Diseases

Volumn 33, Issue 1, 2014, Pages 1-8

  Vidot, Denise C ^a   Prado, Guillermo ^a   Hlaing, Wayway M ^a   Arheart, Kristopher L ^a   Messiah, Sarah E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabis; cardiometabolic risk; diabetes; marijuana; obesity

Indexed keywords

CANNABIS;

ARTICLE; CANNABIS USE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; EPIDEMIC; HUMAN; METABOLIC SYNDROME X; RISK FACTOR; UNITED STATES; CARDIOVASCULAR DISEASES; EPIDEMIOLOGY; MARIJUANA ABUSE; OBESITY; PREVALENCE; PUBLIC HEALTH; TRENDS;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; MARIJUANA ABUSE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PUBLIC HEALTH; RISK FACTORS; UNITED STATES;

EID: 84898977971     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2014.882718     Document Type: Article

References (58)

1. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2012.
2. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: NSDUH Series H-46, HHS Publication No. (SMA) 13-4795, 2013.
3. Kondrad E, Reid A. Colorado family physicians' attitudes toward medical marijuana. J Am Board Fam Med 2013; 26:52-60.
4. Svrakic DM, Lustman PJ, Mallya A, Lynn TA, Finney R, Svrakic NM. Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective. Mo Med 2012; 109:90-8.
5. Office of National Drug Control Policy. Marijuana Resource Center: state laws related to marijuana. Washington, DC: The White House. 2014. http://www. whitehouse.gov/ondcp/state-laws-relatedto-marijuana (accessed March 3, 2014).
6. Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: NSDUH Series H-34, DHHS Publication No. SMA 08-4343, 2008.
7. World Health Organization. Management of substance abuse: cannabis. Geneva, Switzerland: World Health Organization. 2013. http://www.who.int/ substance abuse/facts/cannabis/en/(accessed September 1, 2013).
8. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125:e2-e220.
9. National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention. Heart disease and stroke prevention: addressing the nation's leading killers. Atlanta, GA: Centers for Disease Control and Prevention, 2011.
10. Centers for Disease Control and Prevention (CDC). National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of health and Human Services, Centers for Disease Control and Prevention, 2011.
11. World Health Organization. WHO Global Infobase: BMI/overweight/obesity prevalence, United States of America. Geneva, Switzerland: World Health Organization. 2011 https://apps.who.int/infobase/Indicators.aspx (accessed July 1, 2012).
12. International Diabetes Federation. The IDF consensus definition of the metabolic syndrome in children and adolescents. Brussels, Belgium: IDF Communications, 2007.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
14. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109(3):433-8.
15. Lender D, Sysko SK. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care. Pharmacotherapy 2006; 26: 3S-12S.
16. Johnson KH, Bazargan M, Cherpitel CJ. Alcohol, tobacco, and drug use and the onset of type 2 diabetes among inner-city minority patients. J Am Board Fam Pract 2001; 14:430-6.
17. Rajavashisth TB, Shaheen M, Norris KC, et al. Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open 2012; 2:e000494.
18. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national results on adolescent drug use: overview of key findings 2011. Ann Arbor, MI: Institute for Social Research, The University of Michigan, 2012.
19. Roten AT, Baker NL, Gray KM. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial. Addict Behav 2013; 38:1788-91.
20. United Nations Office of Drugs and Crime. World drug report. New York: United Nations, 2013.
21. Boyce A, McArdle P. Long-term effects of cannabis. Paediatrics and Child Health 2008; 18:37-41.
22. Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007; 369:1047-53.
23. Kirk EP, Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens (Greenwich) 2009; 11:761-5.
24. American Diabetes Association. The cardiometabolic risk initiative. Alexandria, VA: American Diabetes Association. http://professional.diabetes.org/ ResourcesForProfessionals. aspx?cid=60379 (accessed July 1, 2012).
25. American Diabetes Association. Clinical practice recommendations 2002. Diabetes Care 2002; 25:S1-S147.
26. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683-9.
27. Florez H, Palacio A, Tamariz L. Metabolic syndrome, diabetes, and cardiovascular diseases: a serious link. Diabetes Voice 2008; 53:21-4.
28. International Diabetes Federation. The IDF consensus worldwide defintion of the Metabolic Syndrome. Brussels, Belgium: IDF Communications, 2006.
29. National Heart, Lung, and Blood Institute. Third report of the National Cholesterol Education Panel on detection, evaluation, and treatment of high blood cholesterol in adults. NIH Publication No. 01-3670: National Institutes of Health, 2001.
30. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 2011; 34:216-9.
31. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49:403-14.
32. Virmani A, Binienda Z, Ali S, Gaetani F. Links between nutrition, drug abuse, and the metabolic syndrome. Ann N Y Acad Sci 2006; 1074:303-14.
33. Virmani A, Binienda ZK, Ali SF, Gaetani F. Metabolic syndrome in drug abuse. Ann N Y Acad Sci 2007; 1122:50-68.
34. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44:720-32.
35. Greenberg I, Kuehnle J, Mendelson JH, Bernstein JG. Effects of marihuana use on body weight and caloric intake in humans. Psychopharmacology (Berl) 1976; 49:79-84.
36. Foltin RW, Fischman MW, Byrne MF. Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite 1988; 11:1-14.
37. Kirkham TC. Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 2005; 16:297-313.
38. Rodondi N, Pletcher MJ, Liu K, Hulley SB, Sidney S, Coronary Artery Risk Development in Young Adults (CARDIA) Study. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). Am J Cardiol 2006; 98:478-84.
39. Mohs ME, Watson RR, Leonard-Green T. Nutritional effects of marijuana, heroin, cocaine, and nicotine. J Am Diet Assoc 1990; 90:1261-7.
40. Smit E, Crespo CJ. Dietary intake and nutritional status of US adult marijuana users: results from the Third National Health and Nutrition Examination Survey. Public Health Nutr 2001; 4:781-6.
41. Mittleman MA, Lewis RA,Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001; 103:2805-9.
42. Huang DY, Lanza HI, Anglin MD. Association between adolescent substance use and obesity in young adulthood: a groupbased dual trajectory analysis. Addict Behav 2013; 38:2653-60.
43. Hayatbakhsh MR, O'Callaghan MJ, Mamun AA, Williams GM, Clavarino A, Najman JM. Cannabis use and obesity and young adults. Am J Drug Alcohol Abuse 2010; 36:350-6.
44. Le Foll B, Trigo JM, Sharkey KA, Le Strat Y. Cannabis and Delta9;-tetrahydrocannabinol (THC) for weight loss? Med Hypotheses 2013; 80:564-7.
45. Le Strat Y, Le Foll B. Obesity and cannabis use: results from 2 representative national surveys. Am J Epidemiol 2011; 174:929-33.
46. Brook JS, Lee JY, Finch SJ, Balka EB, Brook DW. Physical factors, personal characteristics, and substance use: associations with obesity. Subst Abus 2013; 34:273-6.
47. Cannon CP. Cardiovascular disease and modifiable cardiometabolic risk factors. Clin Cornerstone 2008; 9:24-38.
48. Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med 2013; 126:583-9.
49. Ashton CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth 1999; 83:637-49.
50. Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42:58S-63S.
51. Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002; 42:64S-70S.
52. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:849-63.
53. Nixon PJ. Health effects of marijuana: a review. Pac Health Dialog 2006; 13: 123-9.
54. Aryana A, WilliamsMA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol 2007; 118:141-4.
55. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009; 374:1383-91.
56. Sowers JR. Update on the cardiometabolic syndrome. Clin Cornerstone 2001; 4:17-23.
57. Rosin BL. The progression of cardiovascular risk to cardiovascular disease. Rev Cardiovasc Med 2007; 8(Suppl 4): S3-8.
58. Lau DC. Metabolic syndrome: perception or reality? Curr Atheroscler Rep 2009; 11:264-71.